A comparison of five epidemiological models for transmission of SARS-CoV-2 in India

被引:25
|
作者
Purkayastha, Soumik [1 ]
Bhattacharyya, Rupam [1 ]
Bhaduri, Ritwik [2 ]
Kundu, Ritoban [2 ]
Gu, Xuelin [1 ,3 ]
Salvatore, Maxwell [1 ,3 ,4 ]
Ray, Debashree [5 ,6 ]
Mishra, Swapnil [7 ]
Mukherjee, Bhramar [1 ,3 ,4 ]
机构
[1] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[2] Indian Stat Inst, Kolkata 700108, W Bengal, India
[3] Univ Michigan, Ctr Precis Hlth Data Sci, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA
[7] Imperial Coll London, Sch Publ Hlth, London W2 1PG, England
关键词
Compartmental models; Low and middle income countries; Prediction uncertainty; Statistical models; COVID-19;
D O I
10.1186/s12879-021-06077-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Many popular disease transmission models have helped nations respond to the COVID-19 pandemic by informing decisions about pandemic planning, resource allocation, implementation of social distancing measures, lockdowns, and other non-pharmaceutical interventions. We study how five epidemiological models forecast and assess the course of the pandemic in India: a baseline curve-fitting model, an extended SIR (eSIR) model, two extended SEIR (SAPHIRE and SEIR-fansy) models, and a semi-mechanistic Bayesian hierarchical model (ICM). Methods Using COVID-19 case-recovery-death count data reported in India from March 15 to October 15 to train the models, we generate predictions from each of the five models from October 16 to December 31. To compare prediction accuracy with respect to reported cumulative and active case counts and reported cumulative death counts, we compute the symmetric mean absolute prediction error (SMAPE) for each of the five models. For reported cumulative cases and deaths, we compute Pearson's and Lin's correlation coefficients to investigate how well the projected and observed reported counts agree. We also present underreporting factors when available, and comment on uncertainty of projections from each model. Results For active case counts, SMAPE values are 35.14% (SEIR-fansy) and 37.96% (eSIR). For cumulative case counts, SMAPE values are 6.89% (baseline), 6.59% (eSIR), 2.25% (SAPHIRE) and 2.29% (SEIR-fansy). For cumulative death counts, the SMAPE values are 4.74% (SEIR-fansy), 8.94% (eSIR) and 0.77% (ICM). Three models (SAPHIRE, SEIR-fansy and ICM) return total (sum of reported and unreported) cumulative case counts as well. We compute underreporting factors as of October 31 and note that for cumulative cases, the SEIR-fansy model yields an underreporting factor of 7.25 and ICM model yields 4.54 for the same quantity. For total (sum of reported and unreported) cumulative deaths the SEIR-fansy model reports an underreporting factor of 2.97. On October 31, we observe 8.18 million cumulative reported cases, while the projections (in millions) from the baseline model are 8.71 (95% credible interval: 8.63-8.80), while eSIR yields 8.35 (7.19-9.60), SAPHIRE returns 8.17 (7.90-8.52) and SEIR-fansy projects 8.51 (8.18-8.85) million cases. Cumulative case projections from the eSIR model have the highest uncertainty in terms of width of 95% credible intervals, followed by those from SAPHIRE, the baseline model and finally SEIR-fansy. Conclusions In this comparative paper, we describe five different models used to study the transmission dynamics of the SARS-Cov-2 virus in India. While simulation studies are the only gold standard way to compare the accuracy of the models, here we were uniquely poised to compare the projected case-counts against observed data on a test period. The largest variability across models is observed in predicting the "total" number of infections including reported and unreported cases (on which we have no validation data). The degree of under-reporting has been a major concern in India and is characterized in this report. Overall, the SEIR-fansy model appeared to be a good choice with publicly available R-package and desired flexibility plus accuracy.
引用
收藏
页数:23
相关论文
共 50 条
  • [11] Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates
    Rupam Bhattacharyya
    Ritoban Kundu
    Ritwik Bhaduri
    Debashree Ray
    Lauren J. Beesley
    Maxwell Salvatore
    Bhramar Mukherjee
    Scientific Reports, 11
  • [12] Models of Epidemiological Security Management in the Spread of the SARS-CoV-2 Virus
    Kereselidze, N.
    IFAC PAPERSONLINE, 2021, 54 (13): : 617 - 621
  • [13] Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis
    Nasker, Sourya Subhra
    Nanda, Ananya
    Ramadass, Balamurugan
    Nayak, Sasmita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (21)
  • [14] Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report
    Giandhari, Jennifer
    Pillay, Sureshnee
    Wilkinson, Eduan
    Tegally, Houriiyah
    Sinayskiy, Ilya
    Schuld, Maria
    Lourenco, Jose
    Chimukangara, Benjamin
    Lessells, Richard
    Moosa, Yunus
    Gazy, Inbal
    Fish, Maryam
    Singh, Lavanya
    Khanyile, Khulekani Sedwell
    Fonseca, Vagner
    Giovanetti, Marta
    Alcantara, Luiz Carlos Junior
    Petruccione, Francesco
    Oliveira, Tulio de
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 234 - 241
  • [15] Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission
    Moritz U. G. Kraemer
    Oliver G. Pybus
    Christophe Fraser
    Simon Cauchemez
    Andrew Rambaut
    Benjamin J. Cowling
    Nature Medicine, 2022, 28 : 213 - 213
  • [16] Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India
    Arinaminpathy, Nimalan
    Das, Jishnu
    McCormick, Tyler H.
    Mukhopadhyay, Partha
    Sircar, Neelanjan
    EPIDEMICS, 2021, 36
  • [17] Epidemiological assessment of SARS-CoV-2 reinfection
    Almadhi, Marwa
    Alsayyad, Adel Salman
    Conroy, Ronan
    Atkin, Stephen
    Al Awadhi, Abdulla
    Al-Tawfiq, Jaffar A.
    AlQahtani, Manaf
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 9 - 16
  • [18] Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies
    Doerschug, Anja
    Schwanbeck, Julian
    Hahn, Andreas
    Hillebrecht, Anke
    Blaschke, Sabine
    Mese, Kemal
    Gross, Uwe
    Dierks, Sascha
    Frickmann, Hagen
    Zautner, Andreas E.
    DIAGNOSTICS, 2021, 11 (01)
  • [19] Comparison between five PCR techniques for the diagnosis of SARS-CoV-2
    Tenorio-Abreu, Alberto
    Ruiz-Castillo, Ana
    Francisco Guzman-Gonzalez, Antonio
    Pena-Monje, Alejandro
    Maria Saavedra-Martin, Jose
    Franco-Alvarez De Luna, Francisco
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 (04) : 401 - 405
  • [20] A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations
    Procop, Gary W.
    Brock, Jay E.
    Reineks, Edmunds Z.
    Shrestha, Nabin K.
    Demkowicz, Ryan
    Cook, Eleanor
    Ababneh, Emad
    Harrington, Susan M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (01) : 69 - 78